Drugmaker Baxalta is working with bankers to buy a U.S.-based hematology and oncology specialist valued at about $2 billion.» Read More
Here, we present the top 10 class-action lawsuits in the United States either won, settled or pending, and in terms of damages sought as compiled by LawInfo.com.
Stocks rose Tuesday on the 1-year anniversary of the March 2009 lows. What should investors expect from markets going forward? Ken Croft, CIO and portfolio manager at Croft Value Fund, and Bill McVail, portfolio manager at Turner Small Cap Growth Fund, discussed their market strategies.
It has been over a month and a half since the US House of Representatives passed its version of health care reform and today, the Senate passed its bill. Now the two bills must be reconciled and the debate will continue to heat up. Here are the biggest S&P Health Care gainers and losers over the past 6 months.
There is nothing in this bill that changes our views at Soleil regarding the health care stocks we have been recommending.
Markets fell on Tuesday as the strengthening U.S. dollar chased buyers from equity markets. How should investors prepare their portfolios? Ken Croft, CIO and portfolio manager of Morningstar 5-star-rated Croft Value Fund, shares his investment strategy and stock picks.
Big dividends can mean big payouts for investors and in the current environment, a dividend strategy may not be a bad idea. Joseph Keating, CIO of private asset management at RBC Bank, and George Ball, chairman of Sanders Morris Harris Group, shared their best plays.
Following are the day’s biggest winners and losers. Find out why shares of Dow Chemical and Frontline popped while Pulte Homes and The Buckle dropped.
This weekend, the US House of Representatives passed its version of health care reform and now awaits a version from the Senate. The debate has been heating up since earlier this summer when President Obama was pushing for legislation before the summer recess. Here are the biggest S&P Health Care gainers and losers over while the debate has waged on.
Don't let the pundit-speak about "lagging indicator" or the market's move Friday fool you, the job market is crucial to the stock market right now.
Companies including TD Ameritrade, Coach and Turkey's Turkcell could be on Warren Buffett's radar, according to a quantitative screen by Standard & Poor's.
Stocks slid at the open on Friday after two consecutive trading days of the Dow closing above 10,000. So where should investors be looking now? Kent Croft, CIO and portfolio manager at Croft Value Fund, shared his market strategy.
Following are the day’s biggest winners and losers. Find out why shares of Chicago Bridge & Iron and Sunoco popped while Cypress Semiconductor and Baxter International dropped.
This Friday the CDC is expected to start giving weekly updates on where and how much H1N1 vaccine has been shipped. I'm curious what the demand will truly turn out to be. Some people are growing concerned about the increasing number of pediatric deaths from H1N1 and may rush to get their kids and themselves vaccinated. Others are afraid of or paranoid about the vaccine.
Yesterday and today thousands of kids and healthcare workers around the country started getting AstraZeneca's H1N1 FluMist, the vaccine that's sprayed into the nose. The first shots from Novartis and Sanofi-Aventis may be available later this week. GlaxoSmithKline and Baxter are still waiting for the FDA to approve their vaccines.
The CDC announced today that healthcare workers in Tennessee and Indiana would be amongst the first to get swine flu vaccinations. The outbreak of the H1N1 swine flu virus has sadly killed over 3,900 peope per a report by the World Health Organization (WHO) on September 25th. At the same time the race to battle the pandemic has propped up the shares of biotech companies that promise solutions.
Charles Bobrinskoy, vice chairman and director of research at Ariel Investments and Marc Harris, co-head of Global Research at RBC Capital Markets shared their insights on where to invest in a low volume environment and what investors should be watching for next week.
Stock markets are up 50 percent from the March lows and you need to prepare for a correction. Whether you believe that a 10 percent pullback is reasonable or that something greater is coming, it makes sense to invest with the perspective that a retracement is coming and still be positioned for more market movement forward.
Cramer makes the call on viewers' favorite stocks.
Earnings season should provide a fresh view of the U.S. economy and may shake the stock market out of its summer doldrums.
As flu season goes into high gear in the southern hemisphere, the U.S. Dept. of Homeland Security is preparing for a potential flu outbreak in the United States, according to its top official.